Neurovascular Devices companies specialize in developing innovative medical devices for the treatment of neurological disorders affecting blood vessels in the brain. These organizations contribute to advancements in neurovascular care, aiming to improve patient outcomes.
Latest Neurovascular Devices Companies Updates:
November 2023, Stryker, a leading medical technology company, acquired Surmodics, a developer of innovative embolic protection devices used during neurovascular procedures. This acquisition strengthens Stryker's neurovascular portfolio and expands their offerings for stroke treatment.
Medtronic, another major player, received FDA approval in December 2023 for the Pipeline Flex with Shield technology, a next-generation stent for treating complex brain aneurysms. This device features improved flexibility and deliverability, offering surgeons greater control during the procedure.
Rapid Medical, an Israeli developer of neurovascular devices, achieved significant regulatory milestones in 2023. Their Tigertriever device, used for mechanical thrombectomy during ischemic stroke, received approval from the Pharmaceuticals and Medical Devices Agency in Japan (December 2023) and the National Medical Product Administration in China (August 2023). These approvals expand Rapid Medical's market reach and potential patient impact.
BrainChip, a leading developer of AI-powered neuromorphic processors, announced a collaboration with Abbott in October 2023 to develop an implantable neural interface for real-time stroke detection. This innovative technology has the potential to revolutionize early stroke detection and improve patient outcomes.
List of Neurovascular Devices Key companies in the market:
Neurovascular Devices Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)